Addiction

CRAFTing a response: expanding support options available for families affected by substance use

CRAFTing a response: expanding support options available for families affected by substance use

By Dr. Heather Fulton on November 26, 2024

I recommend Community Reinforcement and Family Training (CRAFT) for families who have a loved one with substance use challenges. It is a is a science-backed approach that helps family members change the way they interact with their loved one that makes change more likely while also helping themselves in the process.

Can we identify patients at risk for Opioid Use Disorder when beginning opioid analgesics for pain from new or ongoing non-cancer causes?

Can we identify patients at risk for Opioid Use Disorder when beginning opioid analgesics for pain from new or ongoing non-cancer causes?

By Jan Klimas, PhD; Michee-Ana Hamilton, MSc; Malcolm Maclure, ScD; Rita McCracken, MD, CCFP, PhD on August 24, 2021

There is growing recognition that opioid prescribing can lead to prescription opioid use disorder (OUD). It is estimated that nearly 115,000 British Columbians have become addicted to opioids. There is a need to safely reduce the volume of new opioid prescriptions for opioid naïve patients.

Learning to meet my patient where they are at – how letting go changed my practice

Learning to meet my patient where they are at – how letting go changed my practice

By Michelle C. Danda, RN, BN on October 10, 2018

I realized that engagement is paramount when working with an ambivalent patient, because the change that they want to make is often important in their life, even if the clinician views it as a problem behavior. Motivational interviewing education has been shown to improve patient alliance and treatment adherence.

Managing opioid use disorder: buprenorphine/naloxone opioid agonist treatment

Managing opioid use disorder: buprenorphine/naloxone opioid agonist treatment

By By Dr. Christy Sutherland and Emily Wagner on November 15, 2017

I no longer offer rapid methadone tapers to my patients. Buprenorphine/naloxone is now recommended as the first-line opioid agonist treatment for opioid use disorder in British Columbia. This is because of its superior safety profile when compared with methadone as well as an easier transition to take home dosing.

Mindshift

This app changed my practice: Mindshift App

By Dr. Daniel Dodek on March 18, 2015

Mental health problems including anxiety, depression and stress make up a large proportion of a typical day in primary care medicine. They also contribute a huge comorbid burden in specialty care. These conditions all require an intense amount of time to help and manage patients.

Visit UBC CPD at ubccpd.ca

UBC CPD website

View all CPD learning activities: virtual, in-person and hybrid conferences, workshops, webinars, online modules, customized community courses, simulation hands-on courses, coaching, mentoring, personalized learning, recordings, and more.

Visit UBC CPD ↗

This field is for validation purposes and should be left unchanged.